ArticleJAAD case reports2025

Cutaneous Rosai-Dorfman disease with near-complete response to the MEK inhibitor cobimetinib.

Vyshnavi Rallapalle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.